Recital 5, Regulation (EU) 2026/795

In forcesince 27 Mar 2026

Infection with bluetongue virus (serotypes 1-24) was listed until recently as a category C+D+E disease in the Annex to Implementing Regulation (EU) 2018/1882 and one of the disease-specific measures to prevent and control was the establishment of an optional eradication programme, in accordance with Article 31(2) of Regulation (EU) 2016/429. The rules for optional eradication programmes for infection with bluetongue virus (serotypes 1-24) are laid down in Section 4 of Chapter 2 of Part II and in Part II of Annex V to Commission Delegated Regulation (EU) 2020/689 [Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211, ELI: http://data.europa.eu/eli/reg_del/2020/689/oj).]. In addition, Article 43 of Delegated Regulation (EU) 2020/689 also lays down rules for the movements of animals into Member States or zones thereof covered by eradication programmes for infection with the bluetongue virus (serotypes 1-24). Consequently, the requirements related to infection with bluetongue virus (serotypes 1-24) for movements within the Union of Delegated Regulation (EU) 2020/688 are, by way of cross-references, those laid down in Article 43 of Delegated Regulation (EU) 2020/689 for movements of animals when entering into a Member State or zone thereof covered by an eradication programme.